ten23 health inaugurates VIVA2 sterile production facility in Visp

ten23 health celebrates the opening of its VIVA2® facility in Visp, increasing the region’s sterile pharmaceutical production capacity and strengthening its position in the life sciences sector.

On September 23, 2024, ten23 health, a leading contract development and manufacturing organization (CDMO), inaugurated its state-of-the-art VIVA2® facility in Visp. This new facility, located near the BioArk Visp technology site, strengthens the region’s sterile drug manufacturing capabilities and positions the canton of Valais as a key hub for life sciences innovation.

The VIVA2® line features state-of-the-art aseptic filling technology, including eight filling heads and the ability to produce over 30 million units per year. Designed to meet the highest safety and quality standards, it is versatile enough to handle a variety of containers, including syringes, cartridges and vials. In addition, VIVA2® incorporates advanced technologies such as headspace-free filling for improved accuracy and a sophisticated process control system for precise monitoring.

VIVA2® also demonstrates ten23 health’s commitment to sustainability. The building is equipped with photovoltaic panels that provide a significant portion of the facility’s energy needs, in line with the company’s long-term vision for green operations.

Combining cutting-edge technology with sustainability

This new facility not only increases ten23 health’s production capacity, but also strengthens Valais’ reputation as a leader in the life sciences sector. The investment is expected to attract further interest from pharmaceutical companies, researchers and investors to the region and strengthen Valais’ international presence in the industry.

CEO Hanns-Christian Mahler commented: “VIVA2® represents a major step forward for ten23 health and the pharmaceutical sector in Valais. This facility combines cutting-edge technology with sustainability, allowing us to meet global demand for sterile medicines while maintaining our eco-responsible approach.”